Warning letters · screened 20 August 2026
Which sellers hold an FDA warning letter
Quick answer
44 of the 402 sellers in this index hold at least one. Every one of them is still listed, at its real price, in its real position — a letter is a fact a reader should have, not a reason to hide the seller. What it changes is on our side: we do not take a commission from a seller holding one.
The list
Ordered by the date of the letter, most recent first. Each entity is named as FDA filed it, including the dba.
They arrive in batches. 13 in June 2026; 18 in February 2026; 13 in September 2025. That is FDA working through a sector rather than singling out one company, which is worth knowing before reading any single row as a verdict.
How this list was built
Search FDA’s own warning-letter page for a company name and it will tell you almost everyone is clean — including companies it has written to. The search box takes what you type and ignores it. That is worth knowing before you accept anyone’s claim to have checked.
So this page works from the whole file instead: all 3,662 letters, searched here rather than through FDA’s box. Before it publishes, the search has to find 110 letters we already hold. If it missed one, nothing here would go up. That is what makes none found on a seller’s page worth reading.
A matching name is not enough on its own. A seller called Found matches a vape company; one called Harbor matches a seafood processor. So a letter is only held against a seller when the letter itself names that seller’s own website. Everything short of that was thrown out.
What a letter does, and does not, mean
A warning letter is FDA telling a company it believes something it is doing violates the law, and giving it a chance to respond. It is not a court finding, not a recall, and not a statement that anyone was harmed. Companies do respond, and matters do get resolved.
Read the subject line, because they differ. Most of these are about claims and misbranding in telehealth marketing — how a product was advertised. That is a different thing from a finding about how the medication itself was made, and the two are worth telling apart before you decide what a letter changes for you.
Every letter here links to the original, so you can read what FDA actually said rather than anyone’s summary of it.
What this does not cover
State action. A pharmacy board order, an attorney-general action or a state licensing matter would not appear in this corpus, and this page says nothing about any of them.
Nor is an absence here a clean bill of health. It means this seller does not appear in FDA’s warning-letter index under a name or domain we could tie to it — no more than that. A company can trade under several brands, and one letter can name an entity that runs four of them.
Screened against FDA’s warning-letter index in August 2026. Letters issued after that date are not here yet. How we verify everything else →